The dry eye treatment developed by TearScience received 510(k) clearance last week, about seven months after the company’s novel medical device received its first marketing go-ahead from the U.S. Food ...
Six years after a blockbuster $40 million funder, Morrisville-based TearScience is at it again, raising a new $19.3 million in equity financing. Six years after a blockbuster $40 million funder, ...
Medical device company TearScience has hired a former Allergan (NYSE:AGN) executive to spearhead European commercialization efforts for its novel dry eye treatment. Deithart Reichardt is now senior ...
Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — TearScience has introduced the LipiFlow Activator II, a ...
Please provide your email address to receive an email when new articles are posted on . MORRISVILLE, N.C. — TearScience has received $44.5 million in Series C funding from new and existing investors ...
February ended with big funding news in the med tech world: HealthCare Royalty Partners' commitment of up to $70 million in debt financing to TearScience, the North Carolina maker of a dry eye ...
TearScience will tap up to a whopping $70 million in new financing to ramp up commercial marketing efforts for its dry eye treatment device. HealthCare Royalty Partners is the sole backer of the new ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its next ...
SANTA ANA, Calif., July 24, 2021 /PRNewswire/ -- Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today revealed new comparative ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--TearScience, Inc., a privately-held medical device company, announced that the Toronto-based Herzig Eye Institute, one of the leading authorities in laser vision ...
MORRISVILLE, N.C. – What’s next for TearScience? The Morrisville-based firm develops and sells innovative methods to diagnose and treat the most common form of dry eyes. Dry eye syndrome impacts 300 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Co-founder of Morrisville's TearScience steps down as CEO ...